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Open access under CC BYSmoke yields determined by a machine-based smoking method cannot adequately predict exposures
experienced by human smokers. In this work, a ﬁlter analysis technique which addresses this fundamen-
tal limitation was used to measure mouth level exposures (MLE) to tar and nicotine in 1330 smokers of
26 brand-styles of US cigarettes covering a wide range of machine-generated yields.
Despite the high degree of variability observed among individual smokers, MLEs were signiﬁcantly cor-
related with machine-derived tar and nicotine yields (r = 0.423 for nicotine MLE/cigarette; r = 0.493 for
tar MLE/cigarette; p < 0.001 for both). Mean tar and nicotine MLE was higher for males than for females.
Mean MLE across races was generally similar. Menthol cigarettes tended toward lower MLE than non-
menthol cigarettes and King-Size cigarettes (83 mm) tended toward lower MLE than 100’s cigarettes
(100 mm), though those trends were not statistically signiﬁcant.
There were good agreements between MLEs measured in a group of 159 subjects smoking their usual
cigarette brand-style on two separate occasions and between two independent groups of subjects smok-
ing the same brand-styles. The results indicated that the ﬁlter analysis method used had sufﬁcient pre-
cision to show similarity among groups.
 2010 Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction
Standardized machine-smoking methods for the measurement
of tar and nicotine yields have been in place in many regions of
the world since the introduction of the Federal Trade Commission
(FTC) method in the US in Public Health Services (1966). The rele-
vance of methods such as the FTC method and the similar Interna-
tional Organization for Standardization (ISO) method has been
frequently questioned by the tobacco control community (e.g.,
National Cancer Institute, 1996; Bates et al., 1999; WHO TobReg
2004, 2008). Recently, the FTC announced they had rescinded their
guidance issued in 1966 that generally permitted statements con-
cerning tar and nicotine yields measured using what was termed
the FTC method (FTC, 2008).
Alternatives to the ISO and FTC methods have been introduced.
These include a method (MA method) introduced by the Common-
wealth of Massachusetts in 1997 (Commonwealth of Massachu-
setts, 1997) and another (Canadian Intense) introduced in Canada
in 2000 (Canada, 2000). Both of these methods are based on ﬁxed
machine-smoking regimes and thus, as is the case for the ISO and
FTC methods, cannot take into account the considerable degree of
variability in human smoking behavior styles. Consequently,-NC-ND license.efforts have been focused on the development of methods for mea-
suring the emissions from cigarettes when smoked under human
smoking conditions.
Methods for determining the exposure of smokers to cigarette
smoke constituents tend to fall into three categories:
1. The analysis of biomarkers of smoke constituents, such as nico-
tine, CO, tobacco speciﬁc nitrosamines (TSNAs), and polycyclic
aromatic hydrocarbons, in human body ﬂuids or expired breath
(e.g., Hecht et al., 2005; Scherer et al., 2007; Shepperd et al.,
2009; Mendes et al., 2009).
2. The recording of human pufﬁng topography (e.g., puff volume,
duration, and frequency) followed by machine smoking using
settings based on the human topography parameters (e.g.,
Creighton et al., 1978; Djordjevic et al., 2000; Hammond
et al., 2006).
3. The analysis of nicotine and tar (or components of tar) depos-
ited in spent cigarette ﬁlters and the derivation of human
smoke yields from the tar and nicotine retention characteristics
of the ﬁlters (e.g., Rawbone, 1984; Baker et al., 1998; Watson
et al., 2004; Shepperd et al., 2006, 2009; St. Charles et al.,
2006, 2010; Polzin et al., 2009; Pauly et al., 2009).
Filter analysis based methods offer a number of advantages over
the biomarker or pufﬁng topography approaches in the assessment
of the yields of smoke constituents produced during human
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their normal smoking environments. Second, they are non-invasive
and therefore should not interfere with normal smoking behavior.
Third, they can be used in large scale population studies. Fourth,
unlike methods based on biomarker analyses, they can provide a
direct estimate of the nicotine and tar yields produced by ciga-
rettes when smoked by humans. These represent the maximum
amounts the smokers obtain from their cigarette.
The use of ﬁlter analysis for estimating nicotine yields to smok-
ers was originally used in the late 1960s and early 1970s (Ashton
and Watson, 1970; Schulz and Seehofer, 1978; Forbes et al.,
1976). Cigarettes marketed at that time were predominantly
unventilated and their tar and nicotine retention characteristics,
or ﬁlter efﬁciencies (FE), were relatively constant over the range
of puff ﬂow rates produced by smokers. However, this is not the
case for modern low yield cigarettes incorporating ventilated ﬁl-
ters where FEs tend to decrease with increasing ﬂow-rates through
the ﬁlter. Consequently, for many years researchers tended not to
use ﬁlter analysis techniques in smoke exposure studies. This situ-
ation changed in 2001 when St. Charles developed a simple but
effective means of avoiding the problem of the ﬂow-rate induced
changes in FE, thereby improving the accuracy of ﬁlter analysis
methodologies. The ﬂow-rate through the mouth-end portion of
the ﬁlter, downstream of the ventilation, is generally above the
range of ﬂow-rates where FE is variable. Thus FEs are generally
constant in the mouth-end portion of the ﬁlter. Additionally, this
region of the ﬁlter avoids the complications caused by nicotine
and other smoke constituents condensing onto the portion of the
ﬁlter adjacent to the tobacco rod. St. Charles (2001) recommended
the analysis of a 10 mm mouth end section of the ﬁlter in order to
minimize problems caused by ﬂow-dependency of FEs and con-
densation. This ‘part-ﬁlter’ technique provides a good estimate of
the tar and nicotine exiting the cigarette during human smoking
(Shepperd et al., 2006) and thus modern ﬁlter analysis techniques
have the capability of producing robust estimates of mouth level
exposures to cigarette smoke in large-scale studies of smokers
(Pauly et al., 2009; Polzin et al., 2009; Shepperd et al., 2009; St.
Charles et al., 2010).Table 1
Details of cigarette brand-styles used in the study.
Brand-style Tar Band Tar (mg/cig) Nicotine (mg
Carlton HP TG1 0.6 0.10
Carlton 100’s SP TG1 0.7 0.13
Carlton 100’s HP TG1 0.8 0.12
Carlton SP TG1 1.1 0.17
Doral ultra lights 100’s HP TG2 4.3 0.41
Camel ultra lights HP TG2 5.0 0.45
Marlboro ultra lights 100’s HP TG2 5.3 0.49
Marlboro ultra lights HP TG2 5.4 0.51
Newport lights HP TG3 8.0 0.65
Marlboro lights menthol HP TG3 8.4 0.71
Pall mall lights 100’s HP TG3 8.5 0.79
Camel lights menthol HP TG3 8.8 0.71
Camel lights HP TG3 9.7 0.83
Marlboro lights 100’s HP TG3 9.9 0.79
Camel lights 99 HP TG3 10.2 0.87
Kool milds HP TG3 10.3 0.84
Marlboro lights HP TG3 11.2 0.83
Marlboro medium HP TG3 11.2 0.79
Pall mall FF 100’s HP TG4 12.8 1.13
Marlboro HP TG4 14.6 1.04
Newport HP TG4 15.2 1.08
Marlboro 100’s HP TG4 15.5 1.18
Camel ﬁlters 100’s HP TG4 16.1 1.31
Camel ﬁlters HP TG4 16.3 1.26
Camel wides HP TG4 17.1 1.25
Kool ﬁlter Kings HP TG4 17.4 1.19
HP = Hard Pack, SP = Soft Pack, TG1 = (<2 mg CFM tar), TG2 = (2–8 mg CFM tar), TG3 = (8–
Market share data obtained from Marlin 2006 database.The mechanics of the smoking process involves two phases:
pufﬁng and inhaling. The puff is achieved entirely as a result of a
mouth action and the smoke generated in the puff process is initially
contained within the mouth. This is due to the closure of the soft
palatewhich physically seals themouth from the airway and allows
the smoker to generate sufﬁcient pressures within the mouth to
draw smoke from the cigarette. In most smokers, inhalation occurs
shortly after the end of the puff. Air is drawn into the mouth, the
mouth ﬁlling procedure is the same as with drinking through a
straw, where it mixes with the smoke and the smoke/air mix is
drawn into the respiratory tract (Rodenstein and Stanescu, 1985;
Fairweather, 1989; Dixon and Baker, 2003; Bernstein, 2004). The
part-ﬁlter analysis technique provides a measure of the amounts
of smoke constituents exiting the cigarette and entering the
smoker’s mouth. This is termed mouth level exposure (MLE).
Measurement of MLE does not take account of any smoke spilled
from the smoker’smouth prior to inhalation or smoke exhaled. Thus
ﬁlter analysis derivedMLEdata represent themaximumavailable to
the smoker rather than absolute smoke amounts retained in, and
absorbed from, the respiratory system.
We describe the ﬁndings of a part-ﬁlter study designed to mea-
sure tar and nicotine MLEs for US consumers of commercially
available cigarettes covering a range of machine-derived smoke
yields and cigarette designs typical of products sold in the US. Of
particular interest was the comparison of MLEs from mentholated
and non-mentholated cigarettes, as concerns have been expressed
that cigarette mentholation may increase the exposure of smokers
to cigarette smoke constituents such as nicotine. The study was
also designed to investigate the reproducibility and repeatability
of measurements obtained in ﬁeld studies using the part-ﬁlter
method.
2. Methods
2.1. Test cigarettes
Twenty-six cigarette brand-styles from the US market were
used in the study. Manufacturers included RJ Reynolds Tobacco/cig) Length Menthol Market Share (%) Subjects (M/F)
KS No 0.03 20/15
100s No 0.06 21/13
100s No 0.13 13/17
KS No 0.04 19/15
100s No 0.34 24/22
KS No 0.15 21/20
100s No 1.27 14/29
KS No 2.38 35/51
KS Yes 0.45 21/21
KS Yes 1.48 17/27
100s No 0.36 23/20
KS Yes 0.34 21/22
KS No 2.91 29/11
100s No 3.39 20/33
100s No 0.13 26/22
KS Yes 0.48 16/26
KS No 12.46 54/49
KS No 1.60 24/17
100s No 0.47 27/13
KS No 7.93 65/40
KS Yes 3.85 61/44
100s No 2.14 29/17
100s No 0.13 32/10
KS No 1.19 35/13
KS No 0.42 37/10
KS Yes 1.00 19/28
14 mg tar), TG4 = (>14 mg tar), KS = King-Size 83 mm length, M = male, F = female.
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brand-styles are shown in Table 1. Cigarettes with different pack-
aging (hard pack, soft pack), length (King Size [83 mm],
100 mm), ﬂavor style (menthol and non-menthol) and Cambridge
Filter Method (CFM) (previously referred to as the FTC method)
smoke yields (0.5–17.9 mg tar) were used in the study. In August
2006, the cigarette brand-styles used in the study accounted for
a 45% share of the US market. Philip Morris and Lorillard brand-
styles were purchased at retail. R.J. Reynolds brand-styles destined
for retail distribution were obtained from the manufacturer.2.2. Measurement of machine smoked tar, nicotine and CO yields
All of the brand-styles were smoked in R.J. Reynolds smoke lab
(ISO 17025 certiﬁed) using the following three machine-smoking
regimes, and mainstream smoke tar, nicotine and CO yields were
measured:
1) The CFM regime: 35 mL puff volume, 2 s puff duration, one
puff per minute, ﬁlter vents intact. (Pillsbury et al., 1969)
2) The Massachusetts regime (MA): 45 mL puff volume, 2 s puff
duration, two puffs per minute, 50% of ﬁlter vents blocked
(Commonwealth of Massachusetts, 1997).
3) The Canadian Intense regime (CI): 55 mL puff volume, 2 s
puff duration, two puffs per minute, 100% of ﬁlter vents
blocked. (Canada, 2000)
Results of the determinations appear in Table 2.2.3. Subjects
A target of 40–50 smokers was set for brand-styles with a mar-
ket share of >0.4%. The target was lowered to 20–40 smokers for
brand-styles with a market share <0.4% because of difﬁculties in
recruiting smokers of these less popular brand-styles. Subject
recruitment was carried out by a market research agency (BellomyTable 2
Yields determined using the Cambridge Filter Method (CFM), Massachusetts (MA) and
Canadian Intense (CI) smoking regimes.
Brand-style Tar Nicotine
CFM MA CI CFM MA CI
Carlton 100’s SP 0.6 7.0 20.2 0.10 0.74 1.36
Carlton 100’s HP 0.7 6.8 20.2 0.13 0.78 1.48
Carlton HP 0.8 7.9 19.4 0.12 0.80 1.48
Carlton SP 1.1 7.3 19.6 0.17 0.79 1.35
Doral ultra lights 100’s HP 4.3 15.9 27.6 0.41 1.26 1.78
Camel ultra lights HP 5.0 15.5 17.9 0.45 1.17 1.29
Marlboro ultra lights 100’s HP 5.3 16.1 27.0 0.49 1.27 1.76
Marlboro ultra lights HP 5.4 16.0 26.9 0.51 1.22 1.58
Newport lights HP 8.0 18.7 23.1 0.65 1.38 1.52
Marlboro lights menthol HP 8.4 21.2 29.7 0.71 1.58 1.85
Camel lights menthol HP 8.5 23.3 32.8 0.79 1.88 2.30
Camel lights HP 8.8 20.8 28.4 0.71 1.59 1.86
Marlboro lights HP 9.7 21.6 26.3 0.83 1.67 1.92
Marlboro lights 100’s HP 9.9 23.9 30.7 0.79 1.75 1.95
Kool milds HP 10.2 24.1 34.0 0.87 1.92 2.37
Camel lights 99 HP 10.3 23.8 31.9 0.84 1.73 2.01
Marlboro medium HP 11.2 22.5 30.0 0.83 1.52 1.83
Pall mall lights 100’s HP 11.2 23.3 31.5 0.79 1.65 1.90
Marlboro HP 12.8 29.5 40.6 1.13 2.37 2.85
Marlboro 100’s HP 14.6 30.5 35.9 1.04 2.08 2.26
Kool ﬁlter Kings HP 15.2 30.2 34.4 1.08 2.25 2.38
Camel ﬁlters HP 15.5 31.5 39.4 1.18 2.25 2.58
Pall mall FF 100’s HP 16.1 32.4 37.1 1.31 2.50 2.75
Newport HP 16.3 32.1 39.3 1.26 2.45 2.78
Camel wides HP 17.1 34.0 37.4 1.25 2.40 2.51
Camel ﬁlters 100’s HP 17.4 30.9 39.9 1.19 2.18 2.60Research, Winston Salem, NC) and eligible smokers were those
who smoked at least seven cigarettes per day and had smoked
one of the brand-styles listed in Table 1 as their usual brand-style
for more than 3 months. Potential participants were excluded if
they reported certain medical conditions including heart disease,
asthma or other lung disease, kidney disease, liver disease, or
pregnancy.
Screening sessions were held during which potential subjects
were provided with protocol details. Those who wished to partici-
pate in the study were enrolled. Informed consent was obtained
from the participants before they commenced the study. The
smokers were recruited from 24 sites across the US.
The study consisted of one or two ‘test-cycles’ depending on the
brand-style analyzed. In the ﬁrst test-cycle, participants visited the
test center, completed a smoking history and demographic ques-
tionnaire, received three packs of their usual brand-style of ciga-
rette and materials for collecting used cigarette butts, and
provided a saliva sample. Two days later each subject revisited
the test center to return their used cigarette butts, provide a sec-
ond saliva sample and complete a brief study survey.
In order to assess the repeatability of the data, smokers of ﬁve
brand-styles (Marlboro Hard Pack (HP), Marlboro Lights 100s,
Marlboro Lights HP, Marlboro Ultra Lights HP and Newport HP)
were invited to participate in a second ‘test-cycle’ involving the
same butt and saliva collection procedures. This test-cycle was
conducted two weeks after the ﬁrst test-cycle.
Four additional independent groups of smokers (replicate
groups) were recruited to smoke Marlboro Hard Pack (HP), Marl-
boro Lights HP, Marlboro Ultra Lights HP and Newport HP in order
to assess the reproducibility of the data.
Participants received $35 or $50 for participating in a test-cycle
dependent on the location of the test center.2.4. Butt collection procedure
On day 1 of a test-cycle, each subject was provided with a foam
block containing 50 capped polyethylene vials in which sample
stability had been demonstrated at room temperature for up to
2 weeks. They were asked to collect all ﬁlters from cigarettes
smoked from the ﬁrst cigarette in the morning to the last in the
evening of day 2 of the test-cycle. Each butt (ﬁlter plus residual to-
bacco) was placed into an individual vial and the vial was sealed
using the screw cap. If a smoker’s consumption exceeded 50 ciga-
rettes per day, the excess butts were not collected but the smoker
was asked to provide a total cigarette count for the day. The sub-
jects returned the butts to the study center on day 3, where the
butts were refrigerated prior to being shipped to Arista Laborato-
ries, Richmond, VA, for analysis.2.5. Butt analysis procedure
The butts were removed from the vials and were counted and
inspected. Butts were not analyzed if they were from an incorrect
brand or were damaged, i.e., burnt, excessively crushed or extin-
guished in liquid. The length of each acceptable butt was measured
from the mouth end of the ﬁlter to the char line. A 10 mm section
was then cut from the mouth end of the ﬁlter. The cut tips were
used to estimate the tar and nicotine mouth level exposures of
the smokers.
The estimation of mouth level exposures (MLEs) relies on using
the relationships between the mainstream smoke yields of tar and
nicotine, and the amounts of tar and nicotine retained within the
ﬁlter tips of the cigarettes. The method used in the study was de-
rived from the part-ﬁlter analysis technique described in detail
by St. Charles et al. (2010).
Table 4
Number of cigarettes smoked per Cambridge ﬁlter for
each calibration regime/brand-style CFM yield
combination.
Regime CFM yield
<8 mg 8–14 mg >14 mg
0 5 5 5
1 5 5 5
2 5 5 3
3 5 – –
4 5 5
5 5 3 3
6 – 5 5
7 5 3 2
8 5 – –
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and nicotine yield vs. nicotine content per tip were prepared for
each of the cigarette brand-styles used by the subjects. Each
brand-style was smoked on a 20-port linear smoking machine
using six different smoking regimes intended to span the range
of human yields of the brand-style. The machine-smoking regimes
are described in Table 3.
The regimes were selected to cover the range of puff volumes
and ﬂow rates typically produced by human smokers and to pro-
duce a wide range of tar and nicotine yields for each cigarette type.
Between two and ﬁve cigarettes were smoked onto each Cam-
bridge ﬁlter (Table 4).
The number of cigarettes per Cambridge ﬁlter pad was set such
that the total particulate matter collected on the pad would not ex-
ceed 150 mg, which would avoid effusion of nicotine through the
ﬁlter. This procedure was conducted in triplicate for each brand-
style and each machine-smoking regime. The mainstream yields
of Total Particulate Matter (TPM), nicotine, water and Nicotine Free
Dry Particulate Matter (NFDPM or tar) were determined by vali-
dated methods [Arista methods are based upon and reference ISO
10315, 10362-1, 3308, 3402, 4387, and 8454 (International
Standards Organization 1995, 1999a,b, 2000a–c)]. The individual
values obtained from the repeat smoking procedures were used
to generate the calibration curves.
The ﬁlter tips from the calibration procedures and from the sub-
jects were extracted using 20 mL methanol incorporating n-hepta-
decane as an internal standard and were analyzed for nicotine
content by GC with FID detection. The tar content of the ﬁlter tips
was determined from the extracts using a UV absorbance method
(columnless HPLC with UV detection (310 nm)) derived from the
methods of Sloan and Curran (1981) and Conner et al. (1990).
Linear regression equations were produced from the calibration
curves for mainstream tar vs. UV absorbance per ﬁlter tip and
mainstream nicotine vs. nicotine content per ﬁlter tip. Separate
regression equations were produced for each brand-style of ciga-
rette used in the study.
The ﬁlter tips from each smoker were extracted and analyzed in
batches of 3–6 ﬁlters. Estimated tar and nicotine MLE was deter-
mined on a per-cigarette basis using the appropriate calibration
regression equations for each batch of ﬁlters analyzed. Average
per-cigarette MLEs were then calculated for each smoker. MLEs
per day were obtained for each subject by multiplying the appro-
priate per cigarette value by the number of returned butts.2.6. Saliva sample collection and analysis
Saliva samples were collected using Salivettes (Sarstedt Inc.,
Newton, NC). The respondents viewed a saliva collection instruc-
tional video then chewed on the Salivette cotton swab for one
minute before placing the swab into the Salivette tube. The Sali-
vettes were placed in sealed plastic bags and stored in a freezerTable 3
Smoking regimes used for part-ﬁlter analysis calibration.
Point (regime) Smoking conditions
Volume (mL) Duration (s) Interval
0 – – –
1 40 2 60
2 40 2 30
3 50 1.5 60
4 50 1.5 60
5 50 1.5 30
6 70 1.5 60
7 70 1.5 30
8 70 1.5 20before being transported frozen to the RJRT laboratory for analysis.
Samples were stored at 10 C prior to analysis for cotinine.
The cotinine levels in the saliva samples were determined using
the method described by Byrd et al. (2005).
2.7. Data analysis
2.7.1. Analysis by individual smoker
Linear regression analyses were conducted using either CFM tar
or nicotine yields as the independent variable and individual smo-
ker MLE values as the dependent variable.
2.7.2. Analysis by brand
The individual smoker MLEs, salivary cotinine and daily ciga-
rette consumption values were averaged for each brand. These
average values were used as dependent variables in linear regres-
sion analyses using either CFM tar or nicotine yields as the inde-
pendent variable.
2.7.3. Analysis by tar band
The data were grouped by tar band into 4 categories based upon
traditional grouping by CFM yield, tar group 1 (TG1, <2 mg CFM
tar), tar group 2 (TG2, 2–8 mg CFM tar), tar group 3 (TG3, 8–
14 mg CFM tar), tar group 4 (TG4, >14 mg CFM tar). A series of
one-way analysis of variance (ANOVA) tests were conducted in or-
der to determine the statistical signiﬁcance of tar band effects on
the various exposure measures. Tukey–Kramer HSD tests were also
conducted when the ANOVA test indicated a signiﬁcant effect of tar
band (p < 0.05).
2.7.4. Menthol and non-menthol comparisons
Separate linear regression analyses were performed for men-
tholated and non-mentholated cigarettes. CFM tar or nicotine yield
was used as the independent variable and individual smoker val-
ues for tar or nicotine MLEs was the dependent variable. The slopesPack tar Yield (mg/cig)
(s) Smoked length/puffs 1–3 mg 4 mg plus
– U U
Four puffs U U
Tipping + 3 mm U U
Four puffs U –
Tipping + 3 mm – U
Tipping + 3 mm U U
Four puffs – U
Tipping + 3 mm U U
Tipping + 3 mm U –
y = 1.3443x + 22.122
R = 0.29
20
22
24
26
28
0.5 0.8 1.1 1.4 1.7 2.0 2.3
CFM Nicotine (mg/cig)
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Fig. 1. Daily cigarette consumption as a function of CFM nicotine yield.
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mentholated brands were compared statistically using a regression
analysis method.
2.7.5. Effect of cigarette length
An analysis similar to the one described above for menthol/non-
menthol was used to compare MLEs for the 100 mm and King-Size
cigarettes.
2.7.6. Gender effect
The MLEs for the male and female respondents were averaged
separately in each of the four tar bands. The male and female mean
values for each tar band were compared using independent two-
sample t-tests.
2.7.7. Race effect
The MLEs for black and white smokers were averaged sepa-
rately in each of the four tar bands. Independent two-sample t-
tests were used to determine the statistical signiﬁcances of a race
effect in each of the tar bands.
2.7.8. Repeatability and reproducibility
In the context of this work, the terms repeatability and repro-
ducibility are not used in the traditional analytical sense to exam-
ine within and between laboratory variability. Here, the terms are
used to examine variability within and between groups of study
subjects. The data obtained from the group of subjects who partic-
ipated in two test cycles (repeatability assessment) were subject to
a series of paired t-tests to determine the statistical signiﬁcance of
any differences between the two test cycles. Additional correlation
coefﬁcients (r values) were obtained for the data obtained from cy-
cle 1 and cycle 2.
Data obtained from the replicate groups smoking the same cig-
arette brands were compared using independent two-sample t-
tests in order to assess the reproducibility of the test methods
across different groups of subjects.
3. Results
A total of 1330 respondents completed the ﬁrst test-cycle of the
study. The breakdown of respondents by gender and brand smoked
is shown in Table 1.
3.1. Cigarette consumption
Two indices of daily cigarette consumption rates were obtained
in the study. Subjects were asked to report their usual daily con-
sumption during their initial visit to the test center. A second mea-
sure of consumption was obtained by counting the number of butts
collected during day 2 of the test cycle. This latter consumption va-
lue was used in the calculation of daily tar and nicotine MLEs. The
average ‘stated’ consumption ﬁgure (17.7 cigs/day) was signiﬁ-
cantly lower (p < 0.0001) than consumption measured using the
butt count method (24.1 cigs/day). The average cigarette consump-
tion per brand, as measured by the butt count, is plotted against
CFM nicotine yield in Fig. 1. There was no signiﬁcant correlation
between these two variables (r = 0.29, p = 0.21).
Provision of gratis cigarettes may be partially responsible for the
difference between the smokers’ self-reported consumption and
the consumption measured from returned cigarette ﬁlters. Despite
being instructed to smoke ‘‘normally,’’ many smokers appear to
have smoked more heavily than their self-reported normal on
the collection day. For example, 27% of the smokers who reported
smoking 15 or fewer cigarettes per day smokedP25 cigarettes and
10% of them smoked P40 cigarettes on the collection day.3.2. Tar and nicotine MLEs
Fig. 2 shows the individual tar and nicotine MLEs plotted
against CFM tar or nicotine yields of the cigarettes smoked by each
subject. Regression lines for the brand-style mean MLEs and yields
obtained using the MA and CI machine-smoking methods are also
shown. Both nicotine (r = 0.423) and tar MLEs per cigarette
(r = 0.493) were signiﬁcantly correlated with CFM nicotine and
tar yields, respectively (p < 0.001 in both cases). Signiﬁcant correla-
tions (p < 0.001) were also obtained for brand-style mean MLEs per
day and CFM tar or nicotine yields (r = 0.280 for per nicotine,
r = 0.326 for tar).
The individual smoker MLEs were averaged for each cigarette
type and the tar and nicotine MLEs per cigarettes appear as the so-
lid circles in Fig. 2. Tar and nicotine MLEs (per cigarette and per
day) for each brand-style are shown in Table 5.
The MLEs for the individual smokers were compared with the
CFM, MA and CI yields of their respective brands. The percentage
of smokers obtaining lower MLEs than the machine yields of their
cigarette brand is shown in Table 6. Less than 25% of smokers ob-
tained lower tar and nicotine MLEs than the CFM yields, more than
75% of non-TG1 smokers obtained tar yields lower than the yields
produced by the MAmethod, and more than 95% of all smokers ob-
tained lower tar MLEs than the yields produced using the CI
method.
Grouping the MLEs by cigarette brand-style removed the inﬂu-
ence of between-smoker variability within each brand-style;
hence, the correlations between MLEs and CFM yields were in-
creased and better-represented the relationship of MLEs and CFM
on a brand-style basis. Signiﬁcant correlations were obtained for
nicotine MLE/cig vs CFM nicotine (r = 0.928), tar MLE/cig vs CFM
tar (r = 0.915), nicotine MLE/day vs CFM nicotine (r = 0.903) tar
MLE/day vs CFM tar (r = 0.893). The individual MLE, cigarette con-
sumption and salivary cotinine data were grouped according to the
tar band of the smokers’ cigarettes (Table 7). Mean MLE tar and
nicotine exposures (both per cigarette and per day) showed signif-
icant increases across the tar bands from the TG1 band to the TG4
band. Mean MLEs per cigarette were also higher than the average
CFM tar and nicotine yields for all four tar bands.
Although the ANOVA test revealed a statistically signiﬁcant dif-
ference (p < 0.001) in the mean salivary cotinine levels of smokers
in the four tar bands this was solely attributed to the higher mean
cotinine level of the TG4 smokers compared with the levels for
smokers from the other three bands (Table 7). There were no sta-
tistically signiﬁcant differences in the mean cotinine levels for
smokers in the TG3, TG2 and TG1 bands. The correlation between
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Fig. 2. Individual smoker and brand-style average tar and nicotine MLEs per cigarette as a function of CFM tar and nicotine yields with regression lines for regulatory and
brand-style average MLE yields.
Table 5
Mean tar and nicotine MLE values and CFM yields for the cigarette brand-styles studied (standard deviations are in parenthesis).
Brand-style CFM tar (mg/cig) Tar MLE (mg/cig) Tar MLE (mg/day) CFM nicotine (mg/cig) Nicotine MLE (mg/cig) Nicotine MLE (mg/day)
Carlton HP 0.6 6 (3) 128 (122) 0.10 0.7 (0.3) 13 (12)
Carlton 100’s SP 0.7 8 (4) 178 (143) 0.13 0.9 (0.4) 20 (16)
Carlton 100’s HP 0.8 8 (5) 196 (142) 0.12 0.8 (0.5) 21 (15)
Carlton SP 1.1 8 (4) 171 (122) 0.17 1.0 (0.5) 20 (15)
Doral ultra lights 100’s HP 4.3 11 (6) 262 (214) 0.41 1.1 (0.6) 25 (20)
Camel ultra lights HP 5.0 12 (5) 294 (243) 0.45 1.1 (0.5) 27 (23)
Marlboro ultra lights 100’s HP 5.3 15 (6) 385 (300) 0.49 1.3 (0.6) 35 (26)
Marlboro ultra lights HP 5.4 13 (6) 330 (225) 0.51 1.3 (0.6) 31 (22)
Newport lights HP 8.0 13 (4) 291 (196) 0.65 1.2 (0.4) 28 (19)
Marlboro lights menthol HP 8.4 17 (8) 347 (260) 0.71 1.4 (0.7) 29 (20)
Pall mall lights 100’s HP 8.5 20 (8) 515 (388) 0.79 1.8 (0.8) 46 (36)
Camel lights menthol HP 8.8 16 (5) 398 (254) 0.71 1.3 (0.4) 33 (21)
Camel lights HP 9.7 18 (7) 383 (252) 0.83 1.5 (0.6) 32 (21)
Marlboro lights 100’s HP 9.9 18 (5) 407 (252) 0.79 1.6 (0.5) 35 (20)
Camel lights 99 HP 10.2 19 (6) 415 (281) 0.87 1.6 (0.6) 36 (24)
Kool milds HP 10.3 17(7) 396 (223) 0.84 1.6 (0.7) 35(19)
Marlboro lights HP 11.2 19 (7) 426 (309) 0.83 1.4 (0.5) 33 (23)
Marlboro medium HP 11.2 17 (6) 412 (339) 0.79 1.4 (0.5) 33 (26)
Pall mall FF 100’s HP 12.8 21 (7) 516 (272) 1.13 1.9 (0.6) 46 (24)
Marlboro HP 14.6 19 (7) 485 (311) 1.04 1.5 (0.6) 37 (23)
Newport HP 15.2 19 (7) 466 (319) 1.08 1.7 (0.6) 40 (28)
Marlboro 100’s HP 15.5 24 (8) 634 (441) 1.18 2.0 (0.7) 52 (36)
Camel ﬁlters 100’s HP 16.1 23 (8) 521 (376) 1.31 2.0 (0.8) 46 (32)
Camel ﬁlters HP 16.3 21 (8) 476 (284) 1.26 1.7 (0.6) 39 (24)
Camel wides HP 17.1 21 (6) 559 (338) 1.25 1.7 (0.6) 46 (27)
Kool ﬁlter Kings HP 17.4 19 (8) 433 (315) 1.19 1.5 (0.6) 34 (24)
CFM = Cambridge Filter Method.
MLE = Mouth level exposure.
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Table 6
Percent of smokers whose tar (nicotine) mouth level exposures was less than yields
obtained using the CFM, MA and CI machine-smoking regimes.
Tar band CFM (%) MA (%) CI (%)
TG4 23 (16) 91 (85) 97 (91)
TG3 10 (9) 80 (67) 96 (82)
TG2 8 (8) 76 (56) 97 (79)
TG1 2 (3) 44 (43) 99 (92)
Total 14 (11) 80 (69) 97 (86)
Figures in parentheses refer to nicotine mouth level exposure; CFM = Cambridge
Filter Method, MA = Massachusetts method, CI = Canadian intense method. Tar
band descriptors as for Table 1.
Fig. 3. Tar:nicotine ratio for each brand-style measured using MLE data and data
from three regulatory machine-smoking regimes (second-order polynomial ﬁt).
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(p < 0.001) but weak (r = 0.34).
There were no statistically signiﬁcant differences (p = 0.194) in
mean daily cigarette consumption rates between the tar bands
(Table 7).
3.3. Tar:nicotine ratios
The tar: nicotine (T:N) ratios for each cigarette type under hu-
man smoking conditions and the three machine-smoking regimes
are shown in Fig. 3 along with a second-order polynomial ﬁt
through the data.
The T:N ratios of the lowest yield cigarettes increased markedly
when moving from the CFM machine-smoking regime to the CI re-
gime. The increase was much less marked for the highest yield
products. This resulted in similar T:N ratios for the lowest (TG1)
and highest (TG4) yield cigarettes under the CI smoking regime.
Although the distributions of the T:N ratios measured under hu-
man smoking conditions and under the MA smoking regime were
ﬂatter than the one produced under the CFM machine-smoking re-
gime, the T:N ratios of the lowest yield cigarettes (TG1) were less
than those for the higher yield cigarettes.
3.4. Gender differences in MLEs
The male and female smoker MLE data were analyzed sepa-
rately and the results are shown in Table 8. For the total group of
smokers, male smokers had signiﬁcantly higher mean tar and nic-
otine MLEs than female smokers (p < 0.001). The mean CFM tar and
nicotine yields were also higher for the all male smokers compared
with all female smokers. This was due to there being fewer female
smokers in the TG4 category. Within each tar band, the CFM yield
was similar for males and females. The differences in MLE were
statistically signiﬁcantly greater for males than females for all
bands other than TG1 (Table 8). These results suggest that the dif-
ference by gender in MLE is more likely attributable to differences
in smoking behavior than choice of cigarette within a tar band.Table 7
CFM nicotine and tar yields, MLEs, salivary cotinine and cigarette consumption rate data
TG1
N = 133
TG2
N = 218
Tar CFM (mg/cig) 0.8 ± 0.2a 5.1 ± 0.4b
Tar MLE (mg/cig) 7.7 ± 3.9a 12.9 ± 6.0b
Tar MLE (mg/day) 167.3 ± 133.1a 319.5 ± 244.6b
Nic CFM (mg/cig) 0.13 ± 0.03a 0.47 ± 0.04b
Nic MLE (mg/cig) 0.85 ± 0.45a 1.19 ± 0.58b
Nic MLE (mg/day) 18.5 ± 14.7a 29.6 ± 22.7b
Cigs/day 22.7 ± 14.1a 24.9 ± 14.1a
Salivary Cot. (ng/mL) 246.6 ± 169.7a 242.6 ± 179.2a
N = number of smokers, MLE = Mouth level exposure, CFM = Cambridge Filter Method, T
tar).
A sufﬁx (a–d) shared in a row indicates no signiﬁcant difference between those tar ban3.5. Racial differences in MLEs
The data were separated according to race and a comparison of
the mean ± SD MLEs obtained by black and white smokers is
shown in Table 9.
In general, MLEs were similar among the different racial groups.
In some cases, black smokers had statistically signiﬁcantly lower
exposure to tar and nicotine on a per-cigarette basis. The differ-
ences tended to be relatively small except in the TG2 group where
all MLE measures were statistically signiﬁcantly lower for black
smokers than for whites.
3.6. Effect of menthol on MLEs
Six menthol brand-styles (four TG3 and two TG4 brand-styles)
were included in the study. In order to determine whether ciga-
rette mentholation inﬂuenced tar and nicotine MLEs the slopes of
the regression lines for individual smoker MLE vs. CFM yield for
the menthol brand-styles were compared with those for the non-
menthol TG3 and TG4 brand-styles. The results for tar and nicotine
MLE per cigarette are shown in Fig. 4.
The regression lines for the menthol cigarettes fell slightly be-
low those for the non-menthol cigarettes suggesting a trend
towards slightly lower MLEs per cigarette for the menthol brand-
styles. However, differences in the slopes and intercepts of the
regression lines were not statistically signiﬁcant. These results
indicate that the mentholated cigarettes were not associated with(mean ± standard deviation) grouped by tar band of cigarette.
TG3
N = 498
TG4
N = 481
ANOVA p value
9.8 ± 1.1c 15.5 ± 1.2d <0.001
17.6 ± 6.8c 20.5 ± 7.7d <0.001
403.1 ± 285.9c 502.0 ± 332.9d <0.001
0.79 ± 0.06c 1.15 ± 0.09d <0.001
1.48 ± 0.58c 1.69 ± 0.64d <0.001
33.9 ± 23.6b 41.5 ± 27.4c <0.001
23.5 ± 13.3a 24.8 ± 13.1a 0.194
246.0 ± 173.7a 295.1 ± 174.8b <0.001
G1 = (<2 mg CFM tar), TG2 = (2–8 mg CFM tar), TG3 = (8–14 mg tar), TG4 = (>14 mg
ds (Tukey–Kramer HSD test, p > 0.05).
Table 8
Effect of gender on tar and nicotine MLEs (mean ± standard deviation).
TG1 n = 73#, 60$ TG2 n = 96#, 122$ TG3 n = 251#, 248$ TG4 n = 305#, 175$ All n = 725#, 605$
Tar MLE (mg/cig) M 7.9 ± 3.9 13.4 ± 6.1 18.8 ± 6.8*** 21.7 ± 7.9*** 18.2 ± 8.2***
F 7.4 ± 4.0 12.5 ± 5.9 16.3 ± 6.6*** 18.3 ± 7.0*** 15.2 ± 7.2***
Tar MLE (mg/day) M 167.1 ± 139.3 360.3 ± 268.0* 440.4 ± 300.0*** 554.9 ± 347.7*** 450.7 ± 327.1***
F 167.6 ± 126.4 287.4 ± 220.4* 365.4 ± 266.3*** 410.0 ± 283.6*** 342.9 ± 262.0***
Nic MLE (mg/cig) M 0.87 ± 0.44 1.23 ± 0.57 1.58 ± 0.58*** 1.79 ± 0.66*** 1.55 ± 0.67***
F 0.83 ± 0.46 1.16 ± 0.58 1.38 ± 0.56*** 1.52 ± 0.57*** 1.32 ± 0.59***
Nic MLE (mg/day) M 18.1 ± 14.7 33.2 ± 24.4* 36.7 ± 24.5** 45.5 ± 28.3*** 38.1 ± 26.7***
F 18.9 ± 14.8 26.8 ± 21.0* 31.1 ± 22.3** 34.4 ± 24.3*** 30.0 ± 22.4***
CFM tar (mg/cig) M 0.8 ± 0.2 5.0 ± 0.5 9.9 ± 1.1 15.5 ± 1.2 10.7 ± 5.0***
F 0.8 ± 0.2 5.1 ± 0.4 9.8 ± 1.1 15.5 ± 1.3 9.6 ± 4.8***
CFM nic (mg/cig) M 0.13 ± 0.03 0.47 ± 0.04 0.79 ± 0.06 1.16 ± 0.10 0.84 ± 0.30***
F 0.13 ± 0.03 0.48 ± 0.04 0.78 ± 0.06 1.14 ± 0.08* 0.76 ± 0.30***
M, # – male smokers, F, $ – female smokers, MLE – mouth level exposure, CFM – Cambridge Filter Method, TG1 = (<2 mg CFM tar), TG2 = (2–8 mg CFM tar), TG3 = (8–14 mg
tar), TG4 = (>14 mg tar).
* p < 0.05 denotes signiﬁcance of gender difference within each tar band (2-sample independent t-test).
** p < 0.01 denotes signiﬁcance of gender difference within each tar band (2-sample independent t-test).
*** p < 0.001 denotes signiﬁcance of gender difference within each tar band (2-sample independent t-test).
Table 9
Effect of race on tar and nicotine MLEs (mean ± standard deviation).
TG1 n = 26B, 91 W TG2 n = 34B,158 W TG3 n = 75B, 369 W TG4 n = 98B, 332 W All n = 223B, 950 W
Tar MLE (mg/cig) B 6.5 ± 4.5 9.5 ± 6.8*** 15.9 ± 8.7* 20.3 ± 8.2 15.8 ± 9.2*
W 7.9 ± 3.6 13.2 ± 5.5*** 17.8 ± 6.2* 20.5 ± 7.5 17.1 ± 7.4*
Tar MLE (mg/day) B 154.9 ± 151.3 210.6 ± 209.4** 381.4 ± 289.1 482.7 ± 358.5 374.2 ± 321.7
W 173.6 ± 130.0 338.1 ± 240.2** 412.0 ± 284.1 513.4 ± 324.3 412.3 ± 298.5
Nic MLE (mg/cig) B 0.71 ± 0.46 0.88 ± 0.64** 1.37 ± 0.73 1.70 ± 0.68 1.36 ± 0.76*
W 0.89 ± 0.42 1.23 ± 0.55** 1.50 ± 0.54 1.69 ± 0.62 1.46 ± 0.61*
Nic MLE (mg/day) B 17.0 ± 15.6 19.7 ± 19.3** 33.3 ± 23.6 40.1 ± 29.8 32.3 ± 26.5
W 19.3 ± 14.6 31.5 ± 22.9** 34.4 ± 23.4 42.5 ± 26.7 35.3 ± 24.8
CFM tar (mg/cig) B 0.8 ± 0.2 4.9 ± 0.5* 9.5 ± 1.2 15.8 ± 1.1** 10.5 ± 5.3
W 0.8 ± 0.2 5.1 ± 0.4* 9.9 ± 1.1 15.4 ± 1.3** 10.1 ± 4.8
CFM nic (mg/cig) B 0.13 ± 0.03 0.46 ± 0.04* 0.76 ± 0.07*** 1.14 ± 0.08 0.81 ± 0.35
W 0.13 ± 0.02 0.48 ± 0.04* 0.79 ± 0.06*** 1.16 ± 0.09 0.80 ± 0.33
B – black smokers, W – white smokers, MLE – mouth level exposure, CFM – Cambridge Filter Method, TG1 = (<2 mg CFM tar), TG2 = (2–8 mg CFM tar), TG3 = (8–14 mg tar),
TG4 = (>14 mg tar).
* p < 0.05 denotes signiﬁcance of race difference within each tar band (2-sample independent t-test).
** p < 0.01 denotes signiﬁcance of race difference within each tar band (2-sample independent t-test).
*** p < 0.001 denotes signiﬁcance of race difference within each tar band (2-sample independent t-test).
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observed for MLEs per day (data not shown).3.7. Effect of cigarette length on MLEs
Ten of the 26 brand-styles used in the study were 100’s style
(typically 96–99 mm in length) whereas the remainder were King
Size (KS, typically 80–84 mm in length). The nicotine and tar MLEs
from the 100’s cigarettes tended to fall above the regression lines
of MLEs vs. CFM yields. Thus for a given CFM yield 100 mm ciga-
rettes tended to produce higher MLEs than the KS cigarettes.
Regression analyses were conducted for the individual smoker
tar and nicotine MLEs vs. CFM yields from the 100 mm and KS cig-
arettes. Although the slopes of the regression lines were marginally
steeper for the 100 mm cigarettes, the differences between the two
lengths in regression slopes and intercepts were not statistically
signiﬁcant (data not shown).3.8. Length of cigarette rod smoked
The lengths of the butts (ﬁlter plus unsmoked tobacco) were
measured in the study. This enabled the calculation of the amounts
of tobacco consumed for each cigarette. The mean lengths (±SD) of
tobacco consumed were 57.7 ± 4.3 mm for the 100’s and46.8 ± 4.0 mm for the KS cigarettes. There were no relationships
between the amounts of tobacco consumed and CFM tar yields
for either the 100’s (r = 0.008) or the KS (r = 0.011) cigarettes. On
average, the cigarettes were smoked to within 5.5 ± 4.6 mm of
the overwrap.3.9. Repeatability testing
To evaluate repeatability of the MLE measurement, smokers of
ﬁve brand-styles were asked to participate in a second test cycle
two weeks after completing the ﬁrst test cycle. Of those eligible
to participate in a second test-cycle, 57% smokers completed a sec-
ond test-cycle. The mean values for MLEs, cigarette consumption
and length of cigarette consumed for the two test-cycles are shown
in Table 10. There were statistically signiﬁcant correlations be-
tween test-cycles 1 and 2 for the individual smoker measures
(p < 0.001 in all cases). Additionally, there were no signiﬁcant dif-
ferences between the two cycles for tar and nicotine MLEs per cig-
arette and cigarette length consumed. This indicates a high degree
of repeatability for the variables measured on a per-cigarette basis.
There was a small but statistically signiﬁcant reduction (6.7%,
p = 0.04) in mean cigarette consumption when the smokers moved
from test-cycle 1 to test-cycle 2. This was reﬂected in small
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Fig. 4. Mean per cigarette tar and nicotine MLEs for both menthol and non-menthol
TG3 and TG4 cigarette brand-styles.
Table 10
Mean MLEs, cigarette consumption and length of cigarette consumed for repeat
testing of the same group of smokers at a two-week interval.
Parameter N Test-cycle
1
Test-cycle
2
r value p
value
Nicotine MLE (mg/cig) 157 1.55 1.54 0.684* 0.692
Nicotine MLE (mg/day) 157 38.4 35.6 0.777* 0.053
Tar MLE (mg/cig) 157 18.9 18.7 0.722* 0.512
Tar MLE (mg/day) 157 469 433 0.795* 0.036
Cigarettes per day 159 25.2 23.5 0.845* 0.040
Length consumed
(mm)
155 51.1 51.0 0.715* 0.852
* p < 0.0001 for signiﬁcance of r value; p values are from a two-tailed paired t-test.
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tion was statistically signiﬁcant for tar MLE per day (p = 0.036).
3.10. Reproducibility testing
Replicate groups of smokers (panels) were recruited for four
brand-styles to evaluate reproducibility of MLE measurementsTable 11
Differences between mean MLE and cigarettes consumption for two independently recrui
Brand-style Nic MLE/cig (%) Nic MLE/day (%)
Marlboro FF 3.0 +3.3
Marlboro Lt +5.7 +12.3
Marlboro ULT +4.1 1.3
Newport FF +3.7 +5.9
% Refer to the differences between the mean scores of panel 2 and panel 1.across independently recruited groups. The differences in the mean
MLE and cigarette consumption values between the two panels for
each of the four brand-styles are shown in Table 11. There were
small MLE differences (2–7%) between the groups for all brand-
styles except Marlboro Lights, where there were 12–13% differ-
ences between the groups for MLEs per day. In viewing the table,
keep in mind that the mean MLE per day is calculated per subject
and is not simply the product of the mean MLE per cigarette and
number of cigarettes smoked.4. Discussion
There have been a number of publications on the use of the
part-ﬁlter method in recent years. Shepperd et al. (2006) reported
the results of a validation study of the method. They compared
estimates of tar and nicotine MLEs from part-ﬁlter analysis with
measures obtained from human smoke duplication and obtained
good correlations between the data produced by the two methods.
St. Charles et al. (2006) reported a highly signiﬁcant correlation be-
tween nicotine MLE and 24hr urinary nicotine metabolites in a
clinical study of 74 smokers. Based on these validation and corre-
lation studies, Pauly et al. (2009) stated the part-ﬁlter method
may be useful in providing proxy measures of mouth level expo-
sure to tobacco smoke constituents.
The part-ﬁlter technique has been used in consumer studies in
Germany (Shepperd et al., 2009) and the US (St. Charles et al.,
2010). The results from our current study are consistent with many
of the ﬁndings of these previous studies. All of these consumer
studies showed statistically signiﬁcant correlations between ISO
or CFM nicotine yields and nicotine MLEs. As in the current study,
there was considerable variability in MLE exposures for smokers of
each cigarette type, and many smokers obtained higher nicotine
MLEs than the ISO or CFM nicotine yields of their brand-styles,
especially smokers of the lower yield products. In two of the stud-
ies, Shepperd et al. (2009) and St. Charles et al. (2010), the differ-
ences in the mean MLEs (tar and nicotine for St. Charles et al.,
2010, nicotine only for Shepperd et al., 2009) were assessed for
smokers of cigarettes from different tar band categories. Shepperd
et al. (2009) reported statistically signiﬁcant differences between
the mean nicotine MLEs for smokers of German ultra light (1 mg
ISO tar yield), light (4 mg ISO tar yield) and full ﬂavor (10 mg tar
yield). Signiﬁcant differences between the mean tar and nicotine
MLEs of smokers of US ultra-low low (1–3 mg CFM tar yield), ul-
tra-low high (4–6 mg CFM tar yield), light (7–12 mg CFM tar yield)
and full ﬂavor (13 mg + CFM tar yield) were reported by St. Charles
et al. (2010).
As the current study and St. Charles et al. (2010) were both con-
ducted in the US using similar size groups of smokers of US prod-
ucts, it is worthwhile directly comparing the results from the two
studies.
St. Charles et al. (2010) reported nicotine and tar MLE values
from 784 smokers of 17 brand-styles of cigarettes yielding 1 mg–
18 mg CFM tar yield. Our study covered a similar range of CFM
tar yields but incorporated a higher number of subjects
(n = 1330) and brand-styles (n = 26) in the ﬁrst test-cycle. Six ciga-
rette brand-styles were common to both studies. Daily cigaretteted groups smoking the same cigarettes.
Tar MLE/cig (%) Tar MLE/day (%) Cig consumption (%)
4.1 +3.4 +6.9
+4.9 +13.3 2.6
+2.3 3.0 +2.4
+3.1 +3.9 +3.0
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yields of the cigarettes in either study. Individual smoker tar MLEs
per cigarette were signiﬁcantly correlated with CFM tar yield in
both studies (r = 0.493 for the current study, 0.546 for St. Charles
et al., 2010). Signiﬁcant correlations were also obtained for individ-
ual smoker nicotine MLEs vs. CFM nicotine yields (r = 0.423 for cur-
rent study, 0.505 for St. Charles et al. (2010). The magnitudes of
these correlation coefﬁcients increased in both studies when mean
MLE values per brand-style instead of MLEs per subject were used
in the regression analyses. This was due to the removal of the sub-
ject-to-subject MLE variability within each brand-style. Both stud-
ies included 100 mm and King-Size cigarettes and the trend
towards slightly higher MLEs from the longer length cigarettes
was present in both studies.
The main differences between the current and St. Charles et al.
(2010) studies were in the magnitudes of the tar and nicotine
MLEs. The mean tar and nicotine MLEs per brand-style and per
tar band were higher in the current study than in St. Charles
et al. (2010) (see Fig. 5).
This is also reﬂected in the fact that St. Charles et al. reported
only 0.3% of their smokers had tar MLEs and 1.4% of smokers had
nicotine MLEs greater than their corresponding Canadian Intense
yields; whereas, more smokers had MLEs higher than the CI yields
in the current study (see Table 6). It is possible that differences in
the compositions of the subject pools and/or cigarette brand-styles
used in the two studies may be factors responsible for the differ-
ences in MLE magnitudes. However, as MLEs for the six brand-
styles common to both studies were also higher in the current than
in the St. Charles et al. (2010) study, differences in brand-style
composition are unlikely to be a major factor. Differences in cali-
bration procedures and composition of the groups of smokers
may have been contributing factor to the observed differences in
the mean MLEs.y = 0.8703x + 7.8519
y = 0.6129x + 6.1198
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Fig. 5. Comparison of tar and nicotine MLEs with data from St. Charles et al. (2010).Previously published part-ﬁlter analysis studies (e.g., Shepperd
et al., 2009; St. Charles et al., 2009) have not addressed the issues
of repeatability and reproducibility for groups of smokers. The re-
sults from the current study show excellent agreements between
tar and nicotine MLEs per cigarette obtained from the same smok-
ers participating in two test-cycles separated by a period of
2 weeks (Table 10). However, the differences between the two
test-cycles were larger for the MLEs per day and were statistically
signiﬁcant for tar MLE per day. This effect can be attributed to a
small but statistically signiﬁcant reduction in measured cigarette
consumption during the 2nd test-cycle.
Reproducibility of the MLE per cigarette results was excellent
for all four brand-styles assessed, as there were only very small dif-
ferences (ranging from 2.3% to 5.7%) between MLEs from the two
sets of independent panels. Good agreements between the panels
for MLEs per day were also observed for three of the four brand-
styles (ranging from 1.3% to 5.9%). Larger differences of 12–13%
were seen in the MLEs per day for one brand-style.
The part-ﬁlter analysis method provides a measure of MLE to
smoke constituents. Lower respiratory tract exposure, retention,
and absorption of smoke constituents into the systemic circulation
may be inﬂuenced by post-puff inhalation factors such as inhala-
tion depth and duration. Consequently, as MLEs provide estimates
of the maximum amounts available for deposition and absorption,
they may not necessarily correlate with other measures of expo-
sure such as levels biomarkers in blood, urine or saliva.
Attempts have been made to examine the relationships be-
tween part-ﬁlter derived measures of nicotine MLE and blood, uri-
nary and salivary biomarkers of nicotine exposure. St. Charles et al.
(2006) compared nicotine MLEs with measures of 24 h urinary nic-
otine metabolites and salivary cotinine in an in-clinic study of a
group of 74 subjects smoking their own brand-styles of US ciga-
rettes over a period of 5 days, during which, samples were ob-
tained each day. They reported signiﬁcant correlations between
part-ﬁlter derived nicotine MLEs per day and urinary nicotine
equivalents (r = 0.81) and salivary cotinine (r = 0.67). The correla-
tion between nicotine MLEs per day and urinary nicotine equiva-
lents (r = 0.81) was stronger than the one between the latter and
salivary cotinine (r = 0.70). More recently, in their in-clinic study
of 150 German smokers, Shepperd et al. (2009) reported signiﬁcant
correlations between nicotine MLEs/day and 24 h urinary nicotine
equivalents (r = 0.83), plasma cotinine (r = 0.83), and salivary coti-
nine (r = 0.79). Cigarette consumption rates were closely moni-
tored in both the St. Charles et al. (2006) and Shepperd et al.
(2009) studies, thus allowing accurate calculations of daily MLEs
from the measured MLE per cigarette data.
Although we obtained a signiﬁcant correlation between nico-
tine MLE per day and salivary cotinine, the strength of the correla-
tion (r = 0.34) was considerably weaker than those reported by St.
Charles et al. (2006) and Shepperd et al. (2009). This may reﬂect
differences in saliva collection techniques. In both the St. Charles
et al. (2006) and Shepperd et al. (2009) studies, saliva samples
were collected at the same time of day for each subject and the col-
lections were supervised by clinically trained staff. There was no
speciﬁed time for saliva sampling in the current study and sample
collection followed video instructions with limited supervision.
This reduced level of control of saliva sampling may have increased
the variability in the saliva cotinine data, thereby degrading the
correlation between nicotine MLE per day and saliva cotinine.
A further indication of the relationships between part-ﬁlter de-
rived nicotine MLEs and biomarkers of nicotine uptake was pro-
vided by St. Charles et al. (2010). In Fig. 10 of their article, they
compared part-ﬁlter derived nicotine MLEs per cigarette obtained
from 784 US smokers with nicotine uptake values per cigarette de-
rived from either plasma nicotine, plasma cotinine, salivary coti-
nine or 24 h urinary nicotine metabolite measures reported in 8
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1985; Benowitz et al., 1988; Byrd et al., 1995; Byrd et al., 1998; Jar-
vis et al., 2001 and Mendes et al., 2008). With one exception (Jarvis
et al., 2001), the trend of an increase in mean nicotine MLE with
increasing CFM nicotine yield was similar for the trends in nicotine
uptakes derived from the published biomarker data.
One of the reasons for the good agreement between nicotine
MLEs and nicotine exposure derived from biomarkers of systemi-
cally absorbed nicotine is the fact that nicotine uptake from the
respiratory tract is relatively insensitive to changes in inhalation
depth and/or duration, as virtually all of the nicotine inhaled is
deposited within the respiratory tract when inhalation occurs
(Armitage et al., 1975; Zacny et al., 1987; Armitage et al., 2004; Ba-
ker and Dixon, 2006; Feng et al., 2007). However, such a relation-
ship between MLE and biomarkers of systemic absorption may
not hold for other smoke constituents, where their respiratory
deposition and systemic uptake may be inﬂuenced by changes in
post-puff inhalation/exhalation characteristics.
Although part-ﬁlter derived measures of smoke component
MLEs may not be suitable as proxy measures of respiratory expo-
sure or systemic uptake of some smoke components, they can pro-
vide a more reliable indication of smoke yields produced under
actual human smoking conditions than the derivation of yields
from traditional biomarkers of smoke exposure or from the moni-
toring and duplication of human pufﬁng topography. There are a
number of reasons why this is so:
1) The majority of biomarkers of smoke component exposure
are metabolites of the parent constituent. There may be con-
siderable inter-individual variations in the rates of metabo-
lism and clearance of the smoke constituent, and the
fractional recoveries of some metabolites may be low. Con-
sequently, a comparison of the levels of a smoke constituent
metabolite between smokers may not provide a reliable
measure of the differences in the yields of the constituent
delivered to the smokers.
2) There may not be a linear relationship between the amounts
of smoke constituents taken from the cigarette by the smo-
ker and the levels of biomarkers in body ﬂuids. Melikian
et al. (2007) compared the emissions of the smoke constitu-
ents: nicotine, NNK and benzo[a]pyrene, measured under
human smoking conditions, with the levels of their respec-
tive metabolites: cotinine, NNAL and 1-hydroxypyrene in
urine. They observed marked decreases in the level of bio-
marker per unit of exposure for all three constituents with
increasing amounts of constituents delivered to the smoker.
3) Many of the biomarkers used in the assessment of cigarette
smoke exposure provide indications of daily exposure to cig-
arette smoke constituents, e.g., plasma or salivary cotinine
as a biomarker for nicotine exposure. Frequently, the levels
of these biomarkers are divided by daily consumption rates
in order to provide an indication of exposure on a per-ciga-
rette basis. Unless cigarette consumption rates are closely
monitored, as was the case in St. Charles et al. (2006) and
Shepperd et al. (2009), errors can occur as result of inaccura-
cies in the reporting of daily consumption rates. Many stud-
ies simply rely on self-reported consumption rates and, as
was seen in our current study, self-reported and actual con-
sumption ﬁgures may differ considerably. However, it must
be stressed that the apparent consumption difference in the
current study may have been inﬂuenced by the provision of
free cigarettes in the ﬁlter collection phase of the study.
4) The recording of human pufﬁng topographies in the labora-
tory or clinic, followed by machine smoking using the
human topography parameters (smoke duplication), can
provide good measures of cigarette emissions during humansmoking (Creighton et al., 1978; Djordjevic et al., 2000;
Hammond et al., 2006). However, the equipment used to
measure pufﬁng topography and/or the laboratory or clinic
setting may interfere with the normal smoking behavior pat-
terns of the smokers and, hence, alter cigarette emissions by
changing crucial parameters such as puff numbers and puff
volumes (Comer and Creighton, 1978; Tobin and Sackner,
1982; Ossip-Klein et al., 1983). Recently, Nelson et al.
(2009) reported results showing the inﬂuence of both the
laboratory setting and the cigarette holder used for puff pro-
ﬁle measurement on nicotine and tar MLEs. In a study of 44
smokers of 6 mg CFM tar yield cigarettes, mean MLEs were
highest for ‘proﬁled’ smoking in the laboratory (18.0 mg
tar, 1.57 mg nicotine), intermediate for ‘un-proﬁled’ smok-
ing in the laboratory (16.9 mg tar, 1.45 mg nicotine) and
lowest for ‘un-proﬁled’ smoking in the ﬁeld (13.4 mg tar,
1.34 mg nicotine). In addition the equipment required to
record and duplicate human smoking proﬁles is complex
and not suitable for use in large-scale monitoring studies
(Polzin et al., 2009).
The part-ﬁlter technique is immune to the problems listed
above and thus can provide reliable measures of the emissions
from different cigarette types under actual human smoking condi-
tions. Polzin et al. (2009) recently described the part-ﬁlter method
as providing excellent versatility and throughput for the estima-
tion of mouth level exposure to cigarette smoke constituents, par-
ticularly when an accurate assessment of exposure on a per-
cigarette basis is required. While Polzin et al. (2009) measured
the levels of solanesol in part-ﬁlters to estimate mouth level expo-
sures to nicotine and TSNAs, the merits described by Polzin et al.
(2009) also apply to mouth level exposures derived from the mea-
surement of nicotine and UV tar in part-ﬁlters.
The trends observed with tar and nicotine MLEs per cigarette vs.
corresponding CFM yields were reﬂected in the MLE per day
trends. An absence of an effect of CFM yield on daily cigarette con-
sumption rates is the reason why the MLE per cigarette and MLE
per day trends were very similar.
The lack of a signiﬁcant relationship between daily cigarette
consumption and CFM yields in our study is not consistent with
the ﬁndings reported by Burns et al. (2001). They analyzed self-re-
ported cigarette consumption data from the 1990 and 1996 Cali-
fornia Tobacco Surveys and reported an inverse relationship
between average daily cigarette consumption data and CFM nico-
tine yield of the cigarettes smoked by participants in the survey.
Burns et al. (2001) claimed daily cigarette consumption increased
as the CFM nicotine yield fell below approximately 0.95 mg/ciga-
rette. However, our results are consistent with those from a large
number of studies reporting no signiﬁcant relationship between
machine-derived smoke yields and consumption from cross-sec-
tional studies of groups of smokers of cigarettes differing in ISO
or CFM tar and nicotine yields (e.g., Russell et al., 1980; Wald
et al., 1981; Rawbone, 1984; Folsom et al., 1984; Gori and Lynch,
1985; Benowitz et al., 1986; Russell et al., 1986; Bridges et al.,
1990; Sepkovic et al., 1990; Hofer et al., 1991; Rosa et al., 1992;
Woodward and Tunstall-Pedoe, 1992; Hee et al., 1995; Djordjevic
et al., 2000; Jarvis et al., 2001; Bowman et al., 2002; Ueda et al.,
2002; Nakazawa et al., 2004; Hecht et al., 2005; St. Charles et al.,
2006, 2010; Mendes et al., 2009; Shepperd et al., 2009). It should
be stressed for most, but not all, of these studies, cigarette con-
sumption rates were self-reported and therefore may be subject
to errors. The exceptions were St. Charles et al. (2006) and Shep-
perd et al. (2009), where exact accounting for daily consumption
rates was assured.
It has also been suggested that smoking a cigarette down to the
ﬁlter may be a mechanism where smokers compensate for a
S36 P.R. Nelson et al. / Regulatory Toxicology and Pharmacology 61 (2011) S25–S38reduction machine-derived nicotine yields (Wilkenfeld et al.,
2000). Consequently, if this was a commonly practiced behavioral
phenomenon one would expect to see an inverse relationship be-
tween the length of tobacco column consumed and the CFM tar
or nicotine yield of the cigarette. Such a relationship was not ob-
served in our study, as the lengths of tobacco rod consumed for
either the 100’s or KS cigarettes were not signiﬁcantly correlated
with CFM tar or nicotine yield. St. Charles et al. (2005) reported
no trends between butt length and CFM tar yield in a study of
803 consumers of 17 brand-styles of US cigarettes with CFM tar
yields in the range of 1–18 mg. They concluded that smoking down
to the ﬁlter does not appear to be a method of compensatory smok-
ing. Our results are in agreement with those produced by St.
Charles et al. (2005).
The mean tar and nicotine MLEs per cigarette and per day for
male smokers were signiﬁcantly higher than the corresponding
values for female smokers for cigarettes in the TG3 and TG4 tar
bands. The gender difference for MLEs per day was also signiﬁcant
in the TG2 tar band (see Table 8). As there were no signiﬁcant gen-
der differences in the mean CFM tar and nicotine yields of the cig-
arettes in each of the four tar bands, the MLE exposure results
imply that, in general, males smoke cigarettes more intensively
than females. This is consistent with the results of pufﬁng topogra-
phy studies in which male smokers are reported to have larger
average and total puff volumes than female smokers when smok-
ing the same cigarette types (Battig et al., 1982; Hofer et al.,
1991; Hee et al., 1995; Eissenberg et al., 1999). These differences
in pufﬁng topography and MLEs highlight the importance of
accounting for potential gender effects in smoker behavior and
exposure studies. For example, if one brand-style of cigarette in a
study is predominantly smoked by females and another is predom-
inantly smoked by males, differences between the cigarettes in
smoke exposure may reﬂect a gender effect rather than an effect
of cigarette design differences. Although, the male/female ratios
differed across the four tar bands in our study, the trends in tar
and nicotine MLEs across the tar bands for all smokers (Table 7)
were present for both the male and female groups of smokers
(Table 8).
Concerns have been raised that menthol cigarettes contribute to
the health disparities between black and white smokers in the US
(Clark et al., 2004). Menthol cigarettes are more popular in the
black than in the white populations of smokers in the US (USDHHS,
1998). It has been suggested that cigarette mentholation may re-
sult in smokers taking larger puffs and deeper inhalations as a re-
sult of the purported cooling effect of menthol in the mouth and
throat (Henningﬁeld et al., 2003; Clark et al., 2004). If the addition
of menthol were to enhance puff volumes in smokers then one
would expect to see higher tar and nicotine MLEs for mentholated
products than for non-mentholated products with similar CFM tar
and nicotine yields. Additionally, one would expect to see higher
MLEs for black smokers than for white smokers. There was no evi-
dence of higher MLEs for mentholated cigarettes in our study, as
the MLEs per cigarette vs CFM yields regression lines for the men-
tholated cigarettes fell slightly below those for the non-menthol
brand-styles (Fig. 4). This indicates a trend towards slightly less
exposure for mentholated products. However, the small differ-
ences in the slopes and intercepts of these regression lines were
statistically insigniﬁcant. Similarly, we found no evidence of higher
MLEs in black smokers. Indeed, mean MLEs per cigarette for black
smokers tended to be lower than the corresponding values for
white smokers (see Table 9).
Our results on mentholated cigarettes are consistent with pub-
lished scientiﬁc data concerning the effect of cigarette menthola-
tion on smoker behavior. Direct comparisons of puff numbers
taken from mentholated and non-mentholated cigarettes were re-
ported in seven studies. No signiﬁcant difference between mentholand non-mentholated cigarettes was reported in four of the studies
(Caskey et al., 1993; Miller et al., 1994; Ahijevych et al., 1996; Pick-
worth et al., 2002). A signiﬁcantly reduced puff number was asso-
ciated with mentholated products in three of the studies (Nil and
Battig, 1989; Jarvik et al., 1994; McCarthy et al., 1995). Puff vol-
umes were reported in six studies. A decrease in puff volume with
mentholated cigarettes was reported in four studies, three of
which were statistically signiﬁcant (Nil and Battig, 1989; Jarvik
et al., 1994 and McCarthy et al., 1995) and one statistically insignif-
icant (Ahijevych et al., 1996). One study reported similar puff vol-
umes for menthol and non-menthol cigarettes (Miller et al., 1994)
and one reported a signiﬁcant increase in puff volume associated
with menthol cigarettes (Ahijevych and Parsley, 1999). These stud-
ies clearly indicate there is no consistent experimental evidence to
support the view that the mentholation of cigarettes increases the
number and/or size of puffs taken by smokers. By contrast, the
experimental evidence tends to show the opposite effect: i.e.,
mentholation is associated with a small reduction in pufﬁng inten-
sity which would be consistent with reduction in tar and nicotine
MLEs. The reason for this behavioral effect is unclear but, as
pointed out by Jarvik et al. (1994), the additional smoke sensory
properties introduced by menthol may create the impression of a
higher amount of smoke taken into the mouth and thereby reduce
puff volumes taken by smokers.
Our MLE results are also consistent with the results from two
studies on the effect of cigarette mentholation on the systemic up-
take of nicotine and CO (Benowitz et al., 2004; Heck et al., 2009).
Both studies reported similar nicotine and CO uptakes from men-
tholated and non-mentholated cigarettes matched in CFM tar
and nicotine yields. Heck et al. (2009) also reported a lack of a
menthol effect on the systemic uptake of NNK.
Currently, there are some authorities (e.g., the European Union)
who set cigarette smoke emissions regulations based on the mea-
surement of tar, nicotine and CO using the ISO machine-smoking
regime. The WHO Study group on tobacco regulation (TobReg)
have recommended that the ISO regime should not be used as a ba-
sis for regulating cigarette smoke emissions (Burns et al., 2008).
They proposed a system whereby cigarettes should be smoked
using the CI smoking regime, and upper levels of the emissions
of cigarette smoke constituents should be set on the basis of con-
stituents per mg of nicotine rather than on absolute levels of
constituents.
The validity of the WHO TobReg proposals to regulate smoke
constituents on a per mg of nicotine hinges upon two key
assumptions:
1) All cigarettes, irrespective of their standard machine smoked
yields, are assumed to produce similar levels of exposure to
nicotine in smokers.
2) The relative composition of mainstream smoke (e.g., the
ratios of toxicants to nicotine) produced using the CI regime
is assumed to closely resemble that produced under human
smoking conditions.
Our results indicate that neither of these conditions is met. First,
there were signiﬁcant differences in nicotine MLEs between smok-
ers of the different tar band cigarettes. Secondly, there were abso-
lute and relative differences in the T:N ratios of the cigarettes when
smoked by humans and when smoked using the CI regime. This
ﬁnding is not surprising given that smoke composition has been
seen to vary substantially based upon machine-smoking regime
applied (Dixon and Borgerding, 2006). Thus, the TobReg proposal
is not relevant to smokers’ exposure.
Recently, Marian et al. (2009) commented on the fact that dif-
ferent machine-smoking regimes cause cigarettes to burn differ-
ently resulting in differences in smoke composition and
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behavior patterns in the development of better methods to com-
pare cigarettes and product design features. The measurement of
tar and nicotine MLEs by part-ﬁlter analysis offers a relatively sim-
ple, non-invasive and reproducible means of obtaining information
on the yields of cigarettes delivered to smokers in their normal
smoking environment. Consequently, the part-ﬁlter technique
may provide a beneﬁcial alternative to the use of machine-smok-
ing methods for regulatory purposes.
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